The Adjuvant Effect of Lucanthone (Miracil D) in Clinical Radiation Therapy
1975; Radiological Society of North America; Volume: 114; Issue: 3 Linguagem: Inglês
10.1148/114.3.729
ISSN1527-1315
AutoresSophie Turner, Robert Bases, Alexander Pearlman, Myron P. Nobler, B Kabakow,
Tópico(s)Lung Cancer Research Studies
ResumoClinical trials were undertaken to determine whether lucanthone (miracil D) affects radiation-induced regression in measurable pulmonary metastases and advanced squamous-cell oral and pharyngeal tumors. The time required for 50% tumor regression was decreased by approximately 50% in those patients who received lucanthone in addition to irradiation. These results indicate that lucanthone has a definite adjuvant effect when used together with irradiation.
Referência(s)